Monday, March 4, 2024

Corcept loses patent spat against Teva, shares tumble

Must read

Mexicali becomes a tiny home capital with new Samara factory

The accessory dwelling unit startup launched in 2022 by an Airbnb cofounder announced this week that it is taking its manufacturing operations...

How far would you go to protect your buyer clients? The Download

The Consumer Federation of America, an industry watchdog, says that the buyer agreements you’re depending on are woefully inadequate to properly protect...

‘Selling the Hamptons’ is back — and the competition is fierce

The moment has arrived — the moment to take charge. This summer, at Inman Connect Las Vegas, July 30-Aug 1, 2024, experience the...

Contracts, crosshairs, commissions: Inman’s Top 5

Mark your calendars for the ultimate real estate experiences with Inman’s upcoming events!...

(Reuters) -A U.S. judge ruled in favor of Israel’s Teva Pharmaceutical Industries in a patent infringement lawsuit brought by Corcept Therapeutics, sparking a frenzied sell-off in shares of the California-based drug developer.

Corcept’s shares fell nearly 38% in trading after the bell.

The lawsuit was tied to Korlym, Corcept’s drug to treat Cushing’s syndrome, which creates an excess of the hormone cortisol and causes high blood sugar, among other things.

Teva has been looking to sell a generic version of Corcept’s Korlym drug. Its application to do so was approved by the U.S. Food and Drug Administration in 2020, but it has not yet launched its product.

Corcept had failed to demonstrate a likelihood of direct infringement of its patent by Teva, a United States district judge ruled.

The companies did not immediately respond to Reuters requests for comment.

(Reporting by Niket Nishant in Bengaluru; Editing by Shounak Dasgupta, Pooja Desai and Sonali Paul)

More articles

Latest article

Mexicali becomes a tiny home capital with new Samara factory

The accessory dwelling unit startup launched in 2022 by an Airbnb cofounder announced this week that it is taking its manufacturing operations...

How far would you go to protect your buyer clients? The Download

The Consumer Federation of America, an industry watchdog, says that the buyer agreements you’re depending on are woefully inadequate to properly protect...

‘Selling the Hamptons’ is back — and the competition is fierce

The moment has arrived — the moment to take charge. This summer, at Inman Connect Las Vegas, July 30-Aug 1, 2024, experience the...

Contracts, crosshairs, commissions: Inman’s Top 5

Mark your calendars for the ultimate real estate experiences with Inman’s upcoming events!...

Want to be a more effective real estate leader? Learn how to coach

ERA Real Estate President Alex Vidal writes that agents are the true heroes in real estate. Leaders need to understand that and...